Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

DEXAIR

DEXAMETHASONE SODIUM PHOSPHATE

Standard Dose
EQ 0.1% PHOSPHATE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DEXAIR is listed in Drugs@FDA under application 088433 (ANDA).

Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% PHOSPHATE Sponsor PHARMAFAIR Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview DEXAIR is listed in Drugs@FDA under application 088433 (ANDA). Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% PHOSPHATE Sponsor PHARMAFAIR Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.